Key facts
- AppliedVR’s last known valuation is $121.0M (Nov 2021).
- It has raised $80.0M; the latest was Later Stage VC ($3.0M) in Apr 2025.
- Notable investors include Techstars, F-Prime Capital, GSR Ventures, SVB Financial Group (Dallas), JAZZ Venture Partners — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for AppliedVR
- ·The full record, as it builds
Funding rounds
No funding rounds for AppliedVR are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AppliedVR
Developer of virtual reality therapeutic devices designed to address unmet needs and improve clinical outcomes for pain management. The company's devices are clinically validated, on-demand, and all-in-one platforms for acute and chronic pain and to adopt non-drug pain management, supporting long-term coping and recovery, enabling doctors to improve clinical outcomes for patients with serious health conditions.
- Sector
- Healthcare
- HQ
- Van Nuys, CA, United States
- Founded
- 2015
- Employees
- 66
- Website
- appliedvr.io/
- Ownership
- Privately Held (backing)
AppliedVR doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AppliedVR shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AppliedVR in its N-PORT filings yet. We sweep new filings monthly.